Good news, nine -valent HPV expansion!Can I play again after the second price?

On August 30, the official public account of Merck China announced that the new indicator of the nine -valent papilloma virus vaccine (winemaking) (hereinafter referred to as the "nine -valent HPV vaccine") has been approved by the National Drug Administration of China, which can 9-45-year-old female vaccination. Earlier, the applicable age of the Nine-valent HPV vaccine in China was 16-26. In order to be able to vaccinate within the "validity period", many young women have tried their best to make an appointment.

In this regard, Hubei Provincial Maternal and Child Health Hospital

Chief Counselor of Gynecology,

Director of Hubei Cervical Cancer Prevention Center

Professor Wu Xufeng said

The nine -valent HPV vaccine "expands age"

Late the people who have a domestic HPV vaccine in China

Women don't have to have "26 years of anxiety"

Young people can also enjoy more comprehensive protection

Nine -valent HPV vaccine "expands age", the prevention surface is wider

Cervical and breast cancer are the most incidence of women. Among them, cervical cancer is caused by HPV (human papilloma virus), and it is also the only cause of all cancers at present, which can be prevented by vaccination with HPV vaccine.

Wu Xufeng introduced that cervical cancer is closely related to 13 high -risk subtypes in the HPV family. In China, 84.5%of cervical cancer is related to the continuous infection of HPV16 and 18.

At present, in addition to the nine -valent HPV vaccine that can be vaccinated in China, there are also imported quadrangers, imported two -price and domestic binary HPV vaccines.

"Price" refers to the number of HPV types that can be prevented. Two -valent HPV vaccine can prevent HPV16 and 18, and the quadrimal HPV vaccine can prevent the four types of HPV types of 6, 11, 16, and 18. 18, 31, 33, 45, 52, 58, HPV types.

Earlier, the applicable age of the Nine-valent HPV vaccine in China was 16-26.

"The approval of the listing or new indications of the HPV vaccine must be approved after being fully verified by clinical research to confirm its protection effect and safety. Broadly. "Wu Xufeng analyzed that the two ages of this expanded HPV vaccine are of great significance: a small age group girl 9-15 is the primary target group of HPV vaccination; women aged 27-45 are relatively high. The risk of HPV infection requires key prevention.

Reminder: Early vaccination Early protection is more important

It is believed that the nine -valent HPV vaccine has more preventive types. Many women have particularly favored the Nine -Valental HPV vaccine. The reservation quota has always been very sought after. Worried that he could not vaccinate the nine -valent HPV vaccine before the age of 26, and some young women even felt anxious for this.

"Nine -valent HPV vaccination age is increased to 45 years old. Women's choice space is greater, which is conducive to eliminating this' 26 -year -old anxiety." Wu Xufeng said. However, she also reminded that if the nine -valent HPV vaccine is not reserved, it is not advisable to wait, "early vaccination and early protection is more meaningful."

Wu Xufeng analyzed that on the one hand, the risk of HPV infection increased significantly after women's starting behavior, and HPV vaccines are preventive vaccines. They have no treatment effect on existing HPV infections, so they must be vaccinated before sexual behavior.

On the other hand, according to clinical data, from the perspective of public health, there is no difference in the effectiveness and effect of two -valent, four -valent, and nine prices in preventing type 16 and 18. Therefore, early vaccination is more valuable than the selection price.

On August 27, a domestic binary HPV vaccine was listed and adapted to women 9-30 years old. A pair of 9 -year -old twin girls were vaccinated at the Cervical Cancer Prevention Center of the Maternal and Child Health Hospital of Hubei Province, becoming the first Hubei and second inocular vaccination (data chart) of the new HPV vaccine.

Can I still vaccinate after the second price?

Citizen Ms. Zhang plans to vaccinate the nine -valent HPV vaccine, but she has not been able to make an appointment to the quota. Seeing her "over -age", she chose to vaccinate the second -cost HPV vaccine. At present, the first vaccination has been completed.

After seeing the news of the nine -valent HPV vaccine, she deliberately consulted the hospital. Can she be replaced with a nine -valent HPV vaccine in the future?

In this regard, Wu Xufeng answered: It is not recommended to replace it with a nine -valent HPV vaccine.

She analyzed that at present, the safety of different varieties of HPV vaccines and the protection effects of the protection effects are very limited. The same vaccination should be used as much as possible.

Citizen Ms. Chen cares that after completing the second -price HPV vaccine, can she inoculate the nine -valent HPV vaccine in the future to achieve the effect of strengthening protection?

"It is not recommended to repeat the HPV vaccine." Wu Xufeng answered. The binary vaccine can prevent most of the cervical cancer. Therefore, it is not recommended that people who have vaccinated the two -price or quadrilateral HPV vaccine continue to vaccinate the nine -valent HPV vaccine.

If the two -price or quadrilateral HPV vaccination is completed, the nine -valent HPV vaccine is still wanted to take over the nine -valent HPV vaccine. It is recommended to interval at least 12 months and the inoculation needle is 3 stitches.

Changjiang Daily reporter Wang Chunlan Correspondent Luo Huarong Huang Jieying

Wuhanfabu

Welcome to follow

Wuhan released the official video number

Edit Ye Tuoli

Source 37 degrees ｜ Yangtze Health Finance Media Wuhan released

- END -